Why Thinly Traded Biotech Akari Is Jumping More Than 150%

Benzinga

•

March 14th, 2019

DESCRIPTION

Akari Therapeutics is up another 30% today after soaring more than 150% yesterday. The thinly-traded biotech stock reported a positive meeting with the FDA. $AKTX Full story here: https://www.benzinga.com/general/biotech/19/03/13352894/why-thinly-traded-biotech-akari-is-jumping-more-than-150

Benzinga

Benzinga delivers fast, actionable financial news and market insights to help investors stay ahead of the curve. From breaking market headlines and earnings coverage to expert analysis on stocks, options, futures, crypto, and macro trends, Benzinga connects audiences with the information that moves markets. Our video content features real-time market commentary, educational segments, and exclusive interviews with industry leaders—designed for active traders, long-term investors, and anyone looking to better understand the financial landscape.